Header cover image

Swiss (SMI) Life Sciences Industry Analysis

UpdatedApr 18, 2024
DataAggregated Company Financials
Companies7
  • 7D-2.9%
  • 3M34.0%
  • 1Y-8.4%
  • YTD35.4%

Over the last 7 days, the Life Sciences industry has dropped 2.9%, driven by declines from every company within the industry. However, the industry is down 8.4% over the past year. As for the next few years, earnings are expected to grow by 19% per annum.

Industry Valuation and Performance

Has the Swiss Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 19 Apr 2024CHF54.6bCHF10.3bCHF1.0b43.6x54.5x5.3x
Sun, 17 Mar 2024CHF52.8bCHF10.2bCHF1.0b44.7x52.6x5.2x
Tue, 13 Feb 2024CHF48.5bCHF10.2bCHF1.0b43.3x47.6x4.8x
Thu, 11 Jan 2024CHF42.0bCHF9.8bCHF1.5b31.5x28.1x4.3x
Sat, 09 Dec 2023CHF39.3bCHF9.8bCHF1.5b29.9x26.3x4x
Mon, 06 Nov 2023CHF38.8bCHF9.8bCHF1.5b27.3x26x4x
Wed, 04 Oct 2023CHF46.0bCHF9.8bCHF1.5b31.7x30.8x4.7x
Fri, 01 Sep 2023CHF53.3bCHF9.8bCHF1.5b36.8x35.7x5.5x
Sun, 30 Jul 2023CHF53.8bCHF9.8bCHF1.5b36.8x34.8x5.5x
Tue, 27 Jun 2023CHF54.0bCHF9.7bCHF1.6b33.8x33.1x5.6x
Thu, 25 May 2023CHF59.5bCHF9.7bCHF1.6b38.1x36.4x6.1x
Sat, 22 Apr 2023CHF60.7bCHF9.7bCHF1.7b42.8x36.4x6.3x
Mon, 20 Mar 2023CHF56.3bCHF9.7bCHF1.7b40.8x34x5.8x
Wed, 15 Feb 2023CHF57.7bCHF9.6bCHF1.6b33.4x35.3x6x
Fri, 13 Jan 2023CHF53.2bCHF9.2bCHF1.3b39.8x40x5.8x
Sun, 11 Dec 2022CHF50.5bCHF9.2bCHF1.3b37.3x38x5.5x
Tue, 08 Nov 2022CHF50.8bCHF9.2bCHF1.3b39.5x38.3x5.5x
Thu, 06 Oct 2022CHF52.1bCHF9.2bCHF1.3b41.2x40.3x5.7x
Sat, 03 Sep 2022CHF54.4bCHF9.2bCHF1.3b42.5x42.1x5.9x
Mon, 01 Aug 2022CHF57.5bCHF8.9bCHF1.3b35.2x43.9x6.5x
Wed, 29 Jun 2022CHF53.2bCHF8.5bCHF1.1b46.4x49.4x6.3x
Fri, 27 May 2022CHF55.9bCHF8.5bCHF1.1b45.1x51.8x6.6x
Sun, 24 Apr 2022CHF64.4bCHF8.5bCHF1.1b58.5x59.7x7.6x
Tue, 22 Mar 2022CHF68.9bCHF8.2bCHF1.1b51.3x64.8x8.4x
Thu, 17 Feb 2022CHF65.5bCHF8.0bCHF1.1b52.2x61.4x8.2x
Sat, 15 Jan 2022CHF69.6bCHF7.4bCHF929.4m72.6x74.9x9.4x
Mon, 13 Dec 2021CHF79.9bCHF7.4bCHF918.2m84.5x87x10.9x
Wed, 10 Nov 2021CHF78.4bCHF7.4bCHF919.0m81.8x85.4x10.7x
Fri, 08 Oct 2021CHF76.1bCHF7.4bCHF919.7m75.1x82.7x10.3x
Sun, 05 Sep 2021CHF82.1bCHF7.4bCHF920.8m86.4x89.1x11.1x
Tue, 03 Aug 2021CHF75.7bCHF7.4bCHF920.8m60.8x82.2x10.3x
Fri, 07 May 2021CHF61.1bCHF7.1bCHF964.3m60.5x63.4x8.7x
Price to Earnings Ratio

63.4x


Total Market Cap: CHF61.1bTotal Earnings: CHF964.3mTotal Revenue: CHF7.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Life Sciences Industry Price to Earnings3Y Average 51.2x202220232024
Current Industry PE
  • Investors are optimistic on the Swiss Life Sciences industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 54.5x which is higher than its 3-year average PE of 51.2x.
  • The 3-year average PS ratio of 6.9x is higher than the industry's current PS ratio of 5.3x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 13% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare industry?

CH Market-2.11%
Healthcare-1.83%
Life Sciences-2.90%
Clinical Research and Equipment-2.90%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.